Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-038277

Director sold 9,000 shares at an average $93.55 ($841,926)

  • Director acquired 9,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Foster-Cheek Kaye I Director 2018-06-14 Option exercise +9,000 $50.73 $456,570 11,200 D
Foster-Cheek Kaye I Director 2018-06-14 Sale −2,181 $92.62 $202,004 9,019 D
Foster-Cheek Kaye I Director 2018-06-14 Sale −5,980 $93.78 $560,804 3,039 D
Foster-Cheek Kaye I Director 2018-06-14 Sale −839 $94.30 $79,118 2,200 D
Derivatives
Foster-Cheek Kaye I Director 2018-06-14 Option exercise · Stock option (right to buy) −9,000 0 D
Open-market sales · 9,000 sh · avg $93.55 · $841,926
Loading xslF345X03/doc4.xml…